Lataa...
Recent advances of antibody drug conjugates for clinical applications
Antibody drug conjugates (ADCs) normally compose of a humanized antibody and small molecular drug via a chemical linker. After decades of preclinical and clinical studies, a series of ADCs have been widely used for treating specific tumor types in the clinic such as brentuximab vedotin (Adcetris®) f...
Tallennettuna:
| Julkaisussa: | Acta Pharm Sin B |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564033/ https://ncbi.nlm.nih.gov/pubmed/33088681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.04.012 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|